Clinical Trial Update: Behavioral Change Following Alzheimer's Disease (AD) Biomarker Disclosure [NA]

View source ↗

Summary

University of Michigan is conducting a study to assess behavioral changes after Alzheimer’s biomarker disclosure in individuals with mild cognitive impairment a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Amnestic Mild Cognitive Impairment
• Cognitive Impairment

Snippet

Sponsor: University of Michigan | Conditions: Mild Cognitive Impairment, Alzheimer Disease | NA | Status: ACTIVE_NOT_RECRUITING